Please login to the form below

Not currently logged in
Email:
Password:

Oasmia Pharmaceuticals

This page shows the latest Oasmia Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Going for gold

Not a smooth road In September, Sonus Pharmaceuticals revealed that it was suspending development of its new paclitaxel formulation, Tocosol Paclitaxel. ... Oasmia Pharmaceuticals is conducting a phase III clinical development with its liposomal product

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Ulf Jungnelius joins Oasmia Pharmaceuticals Dr Ulf Jungnelius joins Oasmia Pharmaceuticals

    He becomes senior medical advisor. Oasmia Pharmaceuticals has appointed Dr Ulf Jungnelius as its new senior medical advisor. ... in taking oncology blockbusters to regulatory approval and commercial success, to the Oasmia Pharmaceutical team.”.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics